Tigress Financial Maintains Buy on Dolby Laboratories, Raises Price Target to $114

Benzinga · 5h ago
Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:
DLB) with a Buy and raises the price target from $112 to $114.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.